In this study, we present a substantial new resource of iPSCs from both clinically asymptomatic carriers and PRPF31 patients affected by two different mutations, as well as isogenic controls, in order to gain further insight into PRPF31-associated RP and therapeutic response. The gene discussed is PRPF31; the disease is retinitis pigmentosa 1.